rethinkTHC Search
Menu
Study breakdown

A Review of Cannabis in Brain Tumor Care Found Promise for Symptom Management but Major Gaps in Dosing Evidence

ReviewModerate evidence
The takeaway

Cannabis shows promise for managing chemotherapy-related nausea, pain, appetite loss, and seizures in brain tumor patients, with some preclinical evidence for anti-tumor effects, but the literature lacks standardized dosing guidance and rigorous clinical trials.

Neuro-oncologists, brain tumor patients, palliative care specialists, medical cannabis clinicians.

No standardized cannabis dosing guidance exists for brain tumor patients

What the researchers found

Published and anecdotal evidence suggests cannabis may help with chemotherapy-induced nausea and vomiting, appetite stimulation, pain reduction, and seizure management in brain tumor patients. Preclinical evidence suggests potential anti-inflammatory and anti-proliferative effects. However, no standardized dosing guidance exists, and cannabis use is dominated by recreational purposes rather than clinical protocols.

Why it matters

Brain tumor patients have very limited treatment options and often experience severe side effects from chemotherapy. Cannabis could address multiple symptoms simultaneously, but without dosing standards, patients and clinicians are navigating blindly.

The numbers in context

No specific quantitative outcomes reported. Review covers palliative benefits (nausea, pain, appetite, seizures) and preclinical anti-cancer data.

How the study worked

Narrative review of current literature on cannabinoids in brain tumor treatment, covering symptomatic management and potential anti-tumor properties.

What this study cannot tell us

Narrative review without systematic methodology. Relies partly on anecdotal evidence. No meta-analysis possible due to heterogeneous literature. Anti-tumor evidence is preclinical only. Legal barriers limit research quality.

How to read the evidence

Narrative review drawing on limited clinical data and preclinical evidence. Highlights evidence gaps.

When this study was published

Published in 2023.

The bigger picture

Many brain tumor patients already use cannabis, but the evidence base lags behind practice. The regulatory barriers to cannabis research have created a situation where widespread use outpaces the clinical data needed to guide it safely.

Questions still open

  • Could standardized cannabis protocols improve quality of life for brain tumor patients?
  • Will clinical trials of cannabinoids for anti-tumor effects in brain cancer ever be feasible given regulatory barriers?

Common questions

Can cannabis help brain tumor patients?
Evidence suggests cannabis may help manage chemotherapy side effects like nausea, pain, and appetite loss in brain tumor patients, but no standardized dosing protocols exist and rigorous clinical trials are needed.
Does cannabis fight brain tumors?
Preclinical studies show cannabinoids may reduce inflammation and cancer cell proliferation, but this has not been confirmed in clinical trials for brain tumors.

Read the original research

Therapeutic and Supportive Effects of Cannabinoids in Patients with Brain Tumors (CBD Oil and Cannabis).

Current treatment options in oncology, 24(1), 30-44

Citation

Rodriguez-Almaraz, J Eduardo; Butowski, Nicholas. (2023). Therapeutic and Supportive Effects of Cannabinoids in Patients with Brain Tumors (CBD Oil and Cannabis).. Current treatment options in oncology, 24(1), 30-44. https://doi.org/10.1007/s11864-022-01047-y

Explore the wider topic